Alleviation of ginsenoside Rg1 on hematopoietic homeostasis defects caused by lead-acetate

Add time:08/10/2019    Source:sciencedirect.com

The hematopoietic system is one of the potential targets of lead intoxication. Recognition of the lead-related deleterious outcomes promotes us to explore the potential therapeutic intervention. Here, we show that ginsenoside Rg1 (Rg1), extracted from the Chinese herb Panax ginseng, remarkably ameliorates the lead acetate-caused hematological index distortion as well as advanced hematopoietic stem cells (HSCs) aging and aging associated inflammation response. Specifically, Rg1 administration alleviated the increment of aging associated p53-p21-Rb signaling in aged HSCs induced by lead acetate. It also led a reduction of the lead acetate-induced increased inflammation level in blood plasma, which also partly contribute the aged HSCs rejuvenation. In conclusion, our results indicate that ginsenoside Rg1 therapeutically alleviated the essential blood deficits and advanced HSCs aging by lead acetate exposure, by which it could be viewed as a potential candidate for lead acetate-caused blood toxicity treatment.

We also recommend Trading Suppliers and Manufacturers of lead acetate (cas 15347-57-6). Pls Click Website Link as below: cas 15347-57-6 suppliers

Prev:Introducing lead acetate (cas 15347-57-6) into stoichiometric perovskite lewis acid-base precursor for improved solar cell photovoltaic performance
Next:Improving the quality of perovskite based on lead acetate (cas 15347-57-6) for efficient solar cell)